Cargando…
Management of Anaphylaxis During the SARS-CoV-2 Pandemic
PURPOSE OF REVIEW: Management of anaphylaxis during the SARS-CoV-2 pandemic should consider local infection rates so as to not burden local ED at times of pandemic, while also protecting patients from infection risks and progression of anaphylaxis. In this review, we identify a treatment strategy fo...
Autores principales: | Brar, Kanwaljit K., Harizaj, Albana, Nowak-Wegrzyn, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946336/ https://www.ncbi.nlm.nih.gov/pubmed/33723499 http://dx.doi.org/10.1007/s40521-021-00284-0 |
Ejemplares similares
-
Idiopathic Anaphylaxis
por: Nwaru, Bright I., et al.
Publicado: (2017) -
Mast Cell Clonal Disorders: Classification, Diagnosis and Management
por: Onnes, Merel C., et al.
Publicado: (2016) -
Hypersensitivity Reactions to Biologicals: from Bench to Bedside
por: Akarsu, Aysegul, et al.
Publicado: (2020) -
New Biomarkers in Anaphylaxis (Beyond Tryptase)
por: Galvan-Blasco, P., et al.
Publicado: (2022) -
Idiopathic Anaphylaxis: a Perplexing Diagnostic Challenge for Allergists
por: Gulen, Theo, et al.
Publicado: (2021)